SNDL (SNDL) Competitors $1.33 0.00 (0.00%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$1.32 -0.01 (-0.38%) As of 04:11 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNDL vs. IRON, TVTX, SDGR, IDYA, MESO, IMCR, INDV, CGON, VERA, and SPRYShould you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Disc Medicine (IRON), Travere Therapeutics (TVTX), Schrödinger (SDGR), IDEAYA Biosciences (IDYA), Mesoblast (MESO), Immunocore (IMCR), Indivior (INDV), CG Oncology (CGON), Vera Therapeutics (VERA), and ARS Pharmaceuticals (SPRY). These companies are all part of the "pharmaceutical products" industry. SNDL vs. Disc Medicine Travere Therapeutics Schrödinger IDEAYA Biosciences Mesoblast Immunocore Indivior CG Oncology Vera Therapeutics ARS Pharmaceuticals Disc Medicine (NASDAQ:IRON) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, community ranking, institutional ownership, earnings, media sentiment and analyst recommendations. Does the MarketBeat Community believe in IRON or SNDL? SNDL received 83 more outperform votes than Disc Medicine when rated by MarketBeat users. However, 86.57% of users gave Disc Medicine an outperform vote while only 71.94% of users gave SNDL an outperform vote. CompanyUnderperformOutperformDisc MedicineOutperform Votes5886.57% Underperform Votes913.43%SNDLOutperform Votes14171.94% Underperform Votes5528.06% Is IRON or SNDL more profitable? Disc Medicine has a net margin of 0.00% compared to SNDL's net margin of -12.11%. SNDL's return on equity of -8.27% beat Disc Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Disc MedicineN/A -25.24% -23.96% SNDL -12.11%-8.27%-6.96% Do analysts rate IRON or SNDL? Disc Medicine currently has a consensus target price of $93.80, suggesting a potential upside of 127.06%. SNDL has a consensus target price of $3.63, suggesting a potential upside of 172.56%. Given SNDL's higher possible upside, analysts plainly believe SNDL is more favorable than Disc Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09SNDL 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to IRON or SNDL? In the previous week, SNDL had 4 more articles in the media than Disc Medicine. MarketBeat recorded 14 mentions for SNDL and 10 mentions for Disc Medicine. Disc Medicine's average media sentiment score of 0.76 beat SNDL's score of 0.63 indicating that Disc Medicine is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Disc Medicine 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SNDL 6 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, IRON or SNDL? Disc Medicine has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, SNDL has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500. Do institutionals and insiders hold more shares of IRON or SNDL? 83.7% of Disc Medicine shares are owned by institutional investors. 4.2% of Disc Medicine shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has better earnings and valuation, IRON or SNDL? Disc Medicine has higher earnings, but lower revenue than SNDL. Disc Medicine is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDisc MedicineN/AN/A-$76.43M-$3.99-10.35SNDL$920.45M0.38-$127.91M-$0.26-5.12 SummaryDisc Medicine and SNDL tied by winning 9 of the 18 factors compared between the two stocks. Remove Ads Get SNDL News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNDL vs. The Competition Export to ExcelMetricSNDLMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$349.49M$1.17B$5.33B$7.57BDividend YieldN/AN/A5.11%4.32%P/E Ratio-4.299.6921.7217.82Price / Sales0.387.42376.8894.61Price / CashN/A10.4038.1534.64Price / Book0.381.186.474.00Net Income-$127.91M-$56.07M$3.20B$247.23M7 Day Performance-4.32%2.62%2.86%1.45%1 Month Performance-11.92%-10.00%-8.55%-6.24%1 Year Performance-32.83%-42.94%10.58%0.60% SNDL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNDLSNDL2.9383 of 5 stars$1.33flat$3.63+172.6%-30.7%$349.49M$920.45M-4.29580IRONDisc Medicine2.5627 of 5 stars$39.20-4.9%$93.80+139.3%+35.4%$1.36BN/A-9.8530Positive NewsGap DownHigh Trading VolumeTVTXTravere Therapeutics2.5531 of 5 stars$15.17+1.2%$31.46+107.4%+135.9%$1.35B$233.18M-3.70460Analyst ForecastSDGRSchrödinger2.3205 of 5 stars$18.21+1.0%$32.29+77.3%+0.2%$1.33B$207.54M-7.78790Insider TradeNews CoveragePositive NewsGap DownIDYAIDEAYA Biosciences3.4329 of 5 stars$15.14+2.9%$53.58+253.9%-59.1%$1.33B$7M-4.5980High Trading VolumeMESOMesoblast2.6518 of 5 stars$10.40-1.6%$18.00+73.1%+108.3%$1.32B$5.67M0.0080Positive NewsIMCRImmunocore2.1971 of 5 stars$26.28-3.6%$65.18+148.0%-50.8%$1.31B$310.20M-27.66320Analyst ForecastNews CoverageINDVIndivior3.7751 of 5 stars$9.39+2.6%$15.00+59.7%-53.9%$1.29B$1.19B-26.831,164Short Interest ↓Positive NewsCGONCG Oncology1.2512 of 5 stars$16.92-1.6%$63.88+277.5%-46.6%$1.29B$1.14M-11.9261Positive NewsHigh Trading VolumeVERAVera Therapeutics2.9097 of 5 stars$19.94-6.4%$64.67+224.3%-53.6%$1.27BN/A-7.6440Positive NewsHigh Trading VolumeSPRYARS Pharmaceuticals3.1601 of 5 stars$12.83+0.2%$31.00+141.6%+62.2%$1.26B$89.15M-25.1690Gap Down Remove Ads Related Companies and Tools Related Companies Disc Medicine Alternatives Travere Therapeutics Alternatives Schrödinger Alternatives IDEAYA Biosciences Alternatives Mesoblast Alternatives Immunocore Alternatives Indivior Alternatives CG Oncology Alternatives Vera Therapeutics Alternatives ARS Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNDL) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SNDL Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SNDL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNDL Stock Free SNDL Stock Alerts